Published in Nanotoxicology on May 01, 2015
Inflammasome activation in airway epithelial cells after multi-walled carbon nanotube exposure mediates a profibrotic response in lung fibroblasts. Part Fibre Toxicol (2014) 1.10
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials. Br J Pharmacol (2014) 0.90
Is the toxic potential of nanosilver dependent on its size? Part Fibre Toxicol (2014) 0.81
Comprehensive In Vitro Toxicity Testing of a Panel of Representative Oxide Nanomaterials: First Steps towards an Intelligent Testing Strategy. PLoS One (2015) 0.80
Environmental impact of multi-wall carbon nanotubes in a novel model of exposure: systemic distribution, macrophage accumulation, and amyloid deposition. Int J Nanomedicine (2015) 0.80
Nano-risk Science: application of toxicogenomics in an adverse outcome pathway framework for risk assessment of multi-walled carbon nanotubes. Part Fibre Toxicol (2016) 0.80
Exploring the potential role of tungsten carbide cobalt (WC-Co) nanoparticle internalization in observed toxicity toward lung epithelial cells in vitro. Toxicol Appl Pharmacol (2014) 0.80
Kinetics of silica nanoparticles in the human placenta. Nanotoxicology (2013) 0.79
High throughput toxicity screening and intracellular detection of nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.78
Interaction of single and multi wall carbon nanotubes with the biological systems: tau protein and PC12 cells as targets. Sci Rep (2016) 0.78
How should the completeness and quality of curated nanomaterial data be evaluated? Nanoscale (2016) 0.78
The use of the comet assay for the evaluation of the genotoxicity of nanomaterials. Front Genet (2015) 0.77
Differential stress reaction of human colon cells to oleic-acid-stabilized and unstabilized ultrasmall iron oxide nanoparticles. Int J Nanomedicine (2014) 0.77
Acute inflammatory responses of nanoparticles in an intra-tracheal instillation rat model. PLoS One (2015) 0.77
Air-liquid interface exposure to aerosols of poorly soluble nanomaterials induces different biological activation levels compared to exposure to suspensions. Part Fibre Toxicol (2016) 0.75
Proactive Approach for Safe Use of Antimicrobial Coatings in Healthcare Settings: Opinion of the COST Action Network AMiCI. Int J Environ Res Public Health (2017) 0.75
Toxicity of ZnO and TiO2 to Escherichia coli cells. Sci Rep (2016) 0.75
A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements. Int J Nanomedicine (2016) 0.75
Mechanisms Underlying Cytotoxicity Induced by Engineered Nanomaterials: A Review of In Vitro Studies. Nanomaterials (Basel) (2014) 0.75
Nanotoxicity: emerging concerns regarding nanomaterial safety and occupational hard metal (WC-Co) nanoparticle exposure. Int J Nanomedicine (2016) 0.75
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Evaluating the toxicity of airborne particulate matter and nanoparticles by measuring oxidative stress potential--a workshop report and consensus statement. Inhal Toxicol (2008) 2.53
Nanoparticles can cause DNA damage across a cellular barrier. Nat Nanotechnol (2009) 1.56
Reproductive and developmental toxicity of phthalates. J Toxicol Environ Health B Crit Rev (2009) 1.47
Involvement of reactive oxygen species in the metabolic pathways triggered by diesel exhaust particles in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol (2003) 1.46
Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: role of particle surface area and internalized amount. Toxicology (2009) 1.46
The expression and function of the endothelin system in contractile properties of vaginal myofibroblasts of women with uterovaginal prolapse. Am J Obstet Gynecol (2005) 1.43
Nanomaterials for environmental studies: classification, reference material issues, and strategies for physico-chemical characterisation. Sci Total Environ (2009) 1.41
Genotoxicity, cytotoxicity, and reactive oxygen species induced by single-walled carbon nanotubes and C(60) fullerenes in the FE1-Mutatrade markMouse lung epithelial cells. Environ Mol Mutagen (2008) 1.39
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation (2004) 1.31
Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis (2004) 1.28
Accurate prediction of the response of freshwater fish to a mixture of estrogenic chemicals. Environ Health Perspect (2005) 1.25
A weight of evidence approach for hazard screening of engineered nanomaterials. Nanotoxicology (2012) 1.24
Carbon black and titanium dioxide nanoparticles elicit distinct apoptotic pathways in bronchial epithelial cells. Part Fibre Toxicol (2010) 1.22
Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance. J Am Chem Soc (2005) 1.17
Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures. J Pharmacol Exp Ther (2006) 1.16
Induction of oxidative stress, lysosome activation and autophagy by nanoparticles in human brain-derived endothelial cells. Biochem J (2012) 1.15
Natural and synthetic endocrine disrupting compounds (EDCs) in water, sediment and biota of a coastal lagoon. Environ Int (2007) 1.14
We're only in it for the knowledge? A problem solving turn in environment and health expert elicitation. Environ Health (2012) 1.13
Therapeutic nanoparticles in clinics and under clinical evaluation. Nanomedicine (Lond) (2013) 1.11
Impairment of NO-dependent relaxation in intralobar pulmonary arteries: comparison of urban particulate matter and manufactured nanoparticles. Environ Health Perspect (2008) 1.10
Concern-driven integrated approaches to nanomaterial testing and assessment--report of the NanoSafety Cluster Working Group 10. Nanotoxicology (2013) 1.10
Nanoparticles: molecular targets and cell signalling. Arch Toxicol (2010) 1.09
Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells. Cancer Chemother Pharmacol (2011) 1.08
Risk assessment of engineered nanomaterials: a review of available data and approaches from a regulatory perspective. Nanotoxicology (2012) 1.06
Carbon black and titanium dioxide nanoparticles induce pro-inflammatory responses in bronchial epithelial cells: need for multiparametric evaluation due to adsorption artifacts. Inhal Toxicol (2009) 1.06
In vitro assessment of engineered nanomaterials using a hepatocyte cell line: cytotoxicity, pro-inflammatory cytokines and functional markers. Nanotoxicology (2012) 1.06
Fine particulate matter induces amphiregulin secretion by bronchial epithelial cells. Am J Respir Cell Mol Biol (2003) 1.05
Increased mutant frequency by carbon black, but not quartz, in the lacZ and cII transgenes of muta mouse lung epithelial cells. Environ Mol Mutagen (2007) 1.05
Harmonic nanocrystals for biolabeling: a survey of optical properties and biocompatibility. ACS Nano (2012) 1.04
ITS-NANO--prioritising nanosafety research to develop a stakeholder driven intelligent testing strategy. Part Fibre Toxicol (2014) 1.04
Oxidant stress stimulates Ca2+-activated chloride channels in the apical activated membrane of cultured nonciliated human nasal epithelial cells. Am J Physiol Lung Cell Mol Physiol (2005) 1.03
Characterization of contaminated soil and groundwater surrounding an illegal landfill (S. Giuliano, Venice, Italy) by principal component analysis and kriging. Environ Pollut (2003) 1.02
Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles. Nanotoxicology (2013) 1.01
Thresholds for indirect DNA damage across cellular barriers for orthopaedic biomaterials. Biomaterials (2010) 1.01
Biological effects of atmospheric particles on human bronchial epithelial cells. Comparison with diesel exhaust particles. Toxicol In Vitro (2003) 1.00
Deciphering the mechanisms of cellular uptake of engineered nanoparticles by accurate evaluation of internalization using imaging flow cytometry. Part Fibre Toxicol (2013) 0.99
Interleukin-13 interferes with CFTR and AQP5 expression and localization during human airway epithelial cell differentiation. Exp Cell Res (2007) 0.98
The effects of PCBs and dioxins on child health. Acta Paediatr Suppl (2006) 0.97
Physicochemical characteristics and biological activities of seasonal atmospheric particulate matter sampling in two locations of Paris. Environ Sci Technol (2004) 0.97
Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin. ChemMedChem (2009) 0.96
DESYRE: DEcision Support sYstem for the REhabilitation of contaminated megasites. Integr Environ Assess Manag (2007) 0.95
The importance of life cycle concepts for the development of safe nanoproducts. Toxicology (2009) 0.94
Integration of bioavailability, ecology and ecotoxicology by three lines of evidence into ecological risk indexes for contaminated soil assessment. Sci Total Environ (2007) 0.94
Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors. J Med Chem (2010) 0.93
Responses of well-differentiated nasal epithelial cells exposed to particles: role of the epithelium in airway inflammation. Toxicol Appl Pharmacol (2006) 0.92
Polycyclic aromatic hydrocarbon components contribute to the mitochondria-antiapoptotic effect of fine particulate matter on human bronchial epithelial cells via the aryl hydrocarbon receptor. Part Fibre Toxicol (2010) 0.92
Estimation of PCDD/F distribution and fluxes in the Venice Lagoon, Italy: combining measurement and modelling approaches. Chemosphere (2003) 0.92
Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges. Crit Rev Toxicol (2012) 0.92
Microglial reaction induced by noncytotoxic methylmercury treatment leads to neuroprotection via interactions with astrocytes and IL-6 release. Glia (2002) 0.91
An in vitro assessment of panel of engineered nanomaterials using a human renal cell line: cytotoxicity, pro-inflammatory response, oxidative stress and genotoxicity. BMC Nephrol (2013) 0.91
Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity. J Environ Monit (2012) 0.91
Associations between environmental factors and incidence of cutaneous melanoma. Review. Environ Health (2012) 0.91
Endothelin-converting enzyme-1 inhibition and growth of human glioblastoma cells. J Med Chem (2005) 0.90
Inhibition of caspase-dependent mitochondrial permeability transition protects airway epithelial cells against mustard-induced apoptosis. Apoptosis (2006) 0.90
Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms. J Med Chem (2007) 0.90
Nanoparticles in the environment: assessment using the causal diagram approach. Environ Health (2012) 0.89
Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: influence of the ligands on drug efficacies and uptake. J Med Chem (2005) 0.89
Adverse health effects of children's exposure to pesticides: what do we really know and what can be done about it. Acta Paediatr Suppl (2006) 0.89
Targeting the endothelin axis in human melanoma: combination of endothelin receptor antagonism and alkylating agents. Exp Biol Med (Maywood) (2006) 0.89
Weight of evidence approach for the relative hazard ranking of nanomaterials. Nanotoxicology (2010) 0.89
Evaluation of uptake and transport of ultrasmall superparamagnetic iron oxide nanoparticles by human brain-derived endothelial cells. Nanomedicine (Lond) (2012) 0.89
Biological impact assessment of nanomaterial used in nanomedicine. introduction to the NanoTEST project. Nanotoxicology (2013) 0.89
Effects of lung exposure to carbon nanotubes on female fertility and pregnancy. A study in mice. Reprod Toxicol (2013) 0.89
In vitro placental model optimization for nanoparticle transport studies. Int J Nanomedicine (2012) 0.88
Can standard genotoxicity tests be applied to nanoparticles? J Toxicol Environ Health A (2012) 0.88
Bivalve molluscs as a unique target group for nanoparticle toxicity. Mar Environ Res (2011) 0.88
Virtual screening and computational optimization for the discovery of covalent prolyl oligopeptidase inhibitors with activity in human cells. J Med Chem (2012) 0.87
Regional risk assessment for contaminated sites part 2: ranking of potentially contaminated sites. Environ Int (2011) 0.87
Cancer risk and the complexity of the interactions between environmental and host factors: HENVINET interactive diagrams as simple tools for exploring and understanding the scientific evidence. Environ Health (2012) 0.87
In vitro effects of suspensions of selected nanoparticles (C60 fullerene, TiO2, SiO2) on Mytilus hemocytes. Aquat Toxicol (2009) 0.87
Rational design of an organometallic glutathione transferase inhibitor. Angew Chem Int Ed Engl (2009) 0.86
Ruthenium porphyrin compounds for photodynamic therapy of cancer. J Med Chem (2008) 0.86
Immunomodulatory effects of mineral fibres in occupationally exposed workers. Mutat Res (2004) 0.86
Coating-dependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles. Nanotoxicology (2013) 0.86
Anthracene-tethered ruthenium(II) arene complexes as tools to visualize the cellular localization of putative organometallic anticancer compounds. Inorg Chem (2012) 0.85
Importance of agglomeration state and exposure conditions for uptake and pro-inflammatory responses to amorphous silica nanoparticles in bronchial epithelial cells. Nanotoxicology (2011) 0.85
Functionalized pyrrolidine inhibitors of human type II alpha-mannosidases as anti-cancer agents: optimizing the fit to the active site. Bioorg Med Chem (2008) 0.85
Today's epidemics in children: possible relations to environmental pollution and suggested preventive measures. Acta Paediatr Suppl (2006) 0.85